Progetti su finanziamenti competitivi 2014 – 2017

progetti 2014-2017
TITOLORESPONSABILE SCIENTIFICOFONTE DEL FINANZIAMENTOANNO DEL FINANZIAMENTOIMPORTO DEL FINANZIAMENTO
Blood-based biomarker assays for personalized tumour therapy: Value of latest circulating biomarkers (CANCER-ID)
Zamarchi RitaIMI – 11° CALL – 2013
2014
€ 300.000,00
Setup of a multi-site radiation dose management system for the optimization of radiological procedures and the assessment of individual and collective radiation dose
Gabusi MicheleRIC. FINAL. MIN. 2013
2014
€ 178.270,00
Challenging the role of chemotherapy in HER2 positive early breas cancer: PI3KCA pathways alteration and response to neoadjuvant pertuzumab-trastuzumab plus letrozole or paclitaxel in Hormone Receptor positive-HER2 positive breast cancer patients.
Guarneri ValentinaRIC. FINAL. MIN. 2013

2014
€ 150.000,00
Caratterizzazione molecolare dei tumori del colon retto metastatico e valutazione di outcome: progetto di rete
Lonardi SaraRIC. FINAL. REGIONALE 2014
2014
€ 265.000,00
PIK3CA mutations/PTEN loss and infiltrating tumor lymphocytes to personalize therapy in HER2+ early breast cancer
Guarneri ValentinaAIRC - MFAG
2014
€ 198.450,00
MELANOSTRUM (Consorzio internazionale coordinato dal NCI)
Menin ChiaraNCI – USA
2015€ 45.500,00
Sistemi organizzativi sulla presa in carico dei pazienti con metastasi ossee nella Rete Oncologica Veneta
Conte PierFrancoPRIHTA–Regione del Veneto Chiamata 2014
2015€ 125.000,00
Deciphering immune response against glioblastoma to find new targets (IMMUNOGLIO)
Mandruzzato SusannaERA-NET – TRANSCAN-2
2016€ 290.950,00
Studio pilota per valutare il potenziale prognostico delle cellule tumorali circolanti in cani affetti da tumore mammario metastatico – IOV partecipa al progetto come U.O. 5
Facchinetti AntonellaLEGNARO – RC 2014
2016€ 22.000,00
Investigating metabolic heterogeneity in tumors and its modulation by anti-angiogenic drugs
Indraccolo StefanoAIRC – INVESTIGATOR GRANT
2016€ 381.000,00
Towards combined post-exposure prophylaxis and successful treatment of rabiess in humans (ToRRENT)
Rosato AntonioERA-NET - INFECT-ERA
2016€ 198.000,00
UsIng guidelines and beNchmarking to Trigger social entrepreneurship solutions towards better patient-centred cancere care in cENTral Europe (INTENT)
IOVINTERREG CENTRAL EUROPE
20161.825.506,27 (IOV €. 510.763,20)
Integrazione dei programmi di vaccinazione e di screening per la prevenzione del cervicocarcinoma: interventi per ridefinire e implementare nuovi protocolli di screening per le donne vaccinate prima dell'atà di inizio dello screening
Regione Toscana (ISPO - M. Zappa) - Piemonte (CPO) - San Martino (IRCCS AOU) - Basilicata (Uff. Prevenzione) - Emilia Romagna (USL) – IOV (Del Mistro Annarosa)
CCM
2016€. 26.000,00
Impatto di un intervento di educazione a corretti stili di vita, nei pazienti con precedente tuore del colon-retto, stadio II e III: studio prospettico randomizzato
Realdon StefanoLILT 2016
2016€ 74.400,00
Randomized phase II study of Metronomic Cyclophosphamide vs Doxorubicin in Elderly Patients with Advanced Soft Tissue Sarcomas: the MetropholyS trial
Brunello AntonellaMinistero della Salute
2016€ 299.680,00
Tracking the dynamic evolution of ESR1 and PIK3CA mutations on circulating tumor DNA in metastatic breast cancer patients receiving endocrine maintenance treatment: a translational analysis of the prospective, multicenter, randomized MAIN-A study.
Dieci Maria VittoriaMinistero della Salute
2016€ 299.200,00
Liquid biopsy in melanoma: investigating the prognostic/predictive potential of circulating melanoma cells (CMCs) and tumor DNA (ctDNA)
Scaini Maria ChiaraMinistero della Salute
2016€ 283.800,00
Performance evaluation and value assessment for cardioavscular and oncological care path in a regional network context: (IOV - Monitoring recommendations on innovative oncology) drugs: development, adherence, clinical outcomes and pharmacoeconomical impact
Conte PierFrancoMinistero della Salute
2016€ 595.100,00
Precision immunotherapy for cancer treatment (IOV: Unveiling tumor- and antigen-specific immune responses in mice undergoing combinatorial therapy with epigenetic drugs and immune checkpoint inhibitors
Rosato AntonioMinistero della Salute
2016€ 35.000,00
Extensive molecular characterization of initial and recurrent glioblastoma: identification of mismatch repair deficiency as candidate biomarker for treatment with immune checkpoint inhibitors
Zagonel VittorinaFONDAZIONE CELEGHIN
2017€ 100.000,00
Validation and Estimation of Radiation skIn Dose in Interventional Cariology (VERIDIC)
De Monte FrancescaCONCERT
2017€ 13.110,00
Innovative Partnership on Action against Cancer (IPAAC)
IOVJOINT ACTION
2017€ 35.000,00